Compelling evidence indicates that some newborns harboring genetic variants associated with hearing loss might not be identified by current physiologic newborn hearing screening (NBHS) rendering current NBHS protocols suboptimal. Incorporating genomic sequencing into NBHS would improve clinical diagnosis and decrease time to early intervention efforts.
Keywords: Copy number variant interpretation; Early intervention; Genetics; Genomics; Hereditary hearing loss; Newborn hearing screening; Precision medicine; Single nucleotide variant interpretation.
Copyright © 2021 Elsevier Inc. All rights reserved.